Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

Safety and Pharmacokinetics Study of MBX 2109 in Adult Subjects With Normal and Impaired Renal Function

← catalyst calendar

NCT06496217

Sponsored by MBX Biosciences (industry) · MBX — their whole pipeline →.

Phase
Phase 1
Status
Completed
Study type
Interventional
Design
Na · None · Basic science
Enrollment
25actual
Sites
3
Country
United States

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2024-06-13actualWhen the study began enrolling
Primary completion2025-09-04actualThe date the last participant is measured for the primary outcome — the readout window
Study completion2025-09-04actualThe whole study's end, after follow-up
First posted2024-07-11actualWhen this record first appeared on the registry
Results postedWhen the sponsor posted results to the registry
Record updated2025-10-28actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Condition

  • Renal Impairment

Interventions

  • Drug: MBX 2109
  • Drug: MBX 2109
  • Drug: MBX 2109
  • Drug: MBX 2109

Primary outcomes

what the primary-completion date above is the date OF
Area under the plasma concentration-time curve from time 0 extrapolated to infinity (AUC0-∞)
measured Baseline through Day 36
Maximum observed concentration (Cmax)
measured Baseline through Day 36
Area under the plasma concentration-time curve from time 0 to time of last quantifiable sample (AUC0-T)
measured Baseline through Day 36
Apparent clearance (CL/F) (MBX 2109 only)
measured Baseline through Day 36
Time to maximum concentration (Tmax)
measured Baseline through Day 36
Terminal elimination half-life (t1/2)
measured Baseline through Day 36
Apparent volume of distribution (Vz/F) (MBX 2109 only)
measured Baseline through Day 36

Permalink · MBX's whole pipeline · Catalyst calendar · Every registered study · What changed